JBIO – jade biosciences, inc. (US:NASDAQ)
Stock Stats
News
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue [Yahoo! Finance]
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Jade Biosciences (NASDAQ:JBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week [Yahoo! Finance]
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: VANGUARD GROUP INC
Form 8-K Jade Biosciences, Inc. For: Jan 05
Form EFFECT Jade Biosciences, Inc.
Form 424B3 Jade Biosciences, Inc.
Form S-1 Jade Biosciences, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.